Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy.
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis.
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
The Relationship between Specific Cognitive Domains, Fear of Falling, and Falls in People with Multiple Sclerosis.
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis.
Flow Cytometric Assay Detecting Cytotoxicity against Human Endogenous Retrovirus Antigens Expressed on Cultured Multiple Sclerosis Cells.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies.
Lhermitte's Sign: The Current Status.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
Progesterone's role in neuroprotection, a review of the evidence.
Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia.
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
The role of complement in inflammatory diseases from behind the scenes into the spotlight.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Pages
« first
‹ previous
…
409
410
411
412
413
414
415
416
417
…
next ›
last »